Lansoprazole enteric-coated tablets are used to treat gastric ulcer, duodenal ulcer, reflux esophagitis and Zollinger-Ellison syndrome.
This document is the package insert for Dawnrays Lansoprazole Enteric-coated Tablets (15 mg), a proton pump inhibitor used for gastric ulcer, duodenal ulcer, reflux esophagitis, and Zollinger-Ellison syndrome. It provides detailed prescribing information including composition, pharmacology, pharmacokinetics, and regulatory details.
The insert specifies adult dosage of 30 mg once daily (two tablets) for 4-8 weeks depending on indication. It lists adverse reactions across multiple systems, contraindications, precautions for hepatic/renal impairment, and special populations. Storage requires protection from light, sealing, and cool dry conditions not exceeding 20°C. The product is manufactured by Suzhou Dawnrays Pharmaceutical Co., Ltd. under approval number 国药准字 H20103038. This manual is written in Chinese.
| Strength | 15 mg per tablet |
|---|---|
| Packaging | Double aluminum blister packs (various configurations) |
| Shelf Life | 36 months |
| Storage Conditions | Protect from light, sealed, cool (≤20°C) dry place |
| Standard | Chinese Pharmacopoeia 2015 Edition Part 2 |
| Approval Number | 国药准字 H20103038 |
| Manufacturer | Suzhou Dawnrays Pharmaceutical Co., Ltd. |
Adults typically take 30 mg (two 15 mg tablets) once daily for 4-8 weeks depending on the condition.
Store protected from light, sealed, in a cool dry place not exceeding 20°C.